<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180624040219N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-09-19</date_registration>
      <primary_sponsor>Iranshahr University of Medical Sciences</primary_sponsor>
      <public_title>The effect of curative and thermotherapy on the severity of labor pain</public_title>
      <acronym></acronym>
      <scientific_title>Compare effects of cold and heat therapy on labor pain intensity and duration of labor in nulliparous women who referred to Iran haspital</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-09-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>105</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/32217</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>The effect of Thermal Therapy and Cold Therapy on the severity of labor pain and delivery time.</hc_freetext>
      <i_freetext>Intervention 1: First intervention group: In the heat therapy group, the level of heat in the bag is controlled by the forearm of the researcher's hands,the heat bag cover by tine cloth  the first stage is placed in the lower back and in the second stage in the supraPubic and Its duration depends on the desire of woman. The acceptable duration for a first-time heat therapy is at least 60 minutes and in the second stage, at least 5 minutes. The temperature of the hot water bottle is adjusted between 38-40. The severity of pain will be measured in the dilatation 3-4, 7-8, 10-9 and the second stage of delivery with the Visual Analogue Scale (VAS). The duration of the first, second and third stages of labor, the first and fifth minute APGAR, mean heart rate, type of delivery, perineum status and maternal satisfaction will be assessed. Intervention 2: Intervention group: Second intervention group: Cold Therapy. Before of any intervention, the severity of the pain in the 4 cm dilatation is measured by showing a graded ruler. the Ice Bag cover by thin cloth  and put  on back in the first stage and it put in second stage in the perineal and suprapubic . The acceptable duration for cold therapy is at least 60 minutes in the first stage and at least 5 minutes in the second stage. The temperature of the ice bag is between 0 to -5 degrees.The severity of pain will be measured in the dilatation 3-4, 7-8, 10-9 and the second stage of delivery with the Visual Analogue Scale (VAS). The duration of the first, second and third stages of labor, the first and fifth minute APGAR, type of delivery, perineum status and maternal satisfaction will be assessed. Intervention 3: Control group: For the control group, the usual care is done.The severity of pain will be measured in the dilatation 3-4, 7-8, 10-9 and the second stage of delivery with the Visual Analogue Scale (VAS). The duration of the first, second and third stages of labor, the first and fifth minute APGAR, type of delivery, perineum status and maternal satisfaction will be assessed.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mahnaz Didehvar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Balooch Blvd</address>
        <city>Iranshahr</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9914786138</zip>
        <telephone>+98 54 3721 0481</telephone>
        <email>didevar.m@gmail.com</email>
        <affiliation>Iranshahr University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mahnaz Didehvar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Balooch Boulvar</address>
        <city>Iranshahr</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9914786138</zip>
        <telephone>+98 54 3721 0481</telephone>
        <email>didevar.m@gmail.com</email>
        <affiliation>Iranshahr University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1- Age 18 to 35 years
2. At the beginning of the active phase of labor (dilatation 3 to 4CM)
3- Gestational age 37- 41 weeks
4- Single-crowned pregnancy
5- Cephalic sedation</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>35 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>1- Diagnosis of mental and anatomical disorders (psychosis, schizophrenia, uterine anomalies, pelvic stenosis
2. Chronic known disease (heart disease, pulmonary, hypertension, diabetes
Skin diseases (any lesion, inflammation and eczema in the area of thermal therapy and cold therapy
Gestational hypertension
Cephalopods10. Poly and Oligo-Hydramonus with ultrasound
Reduce fetal movements12- IUGR13. Fetal death1
Rupture of curtains for more than 12 hours.
Discontinuity of the head of the fetus with the pelvis
Abnormal heartbeat patterns
History of chronic pelvic pain
Infertility record
Any complications experienced during the study (abnormal placenta, abnormal position of the embryo, umbilical cord prolapse)
unwillingness to continue the intervention
Use of any medication or analgesia</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>First intervention group: In the heat therapy group, the level of heat in the bag is controlled by the forearm of the researcher's hands,the heat bag cover by tine cloth  the first stage is placed in the lower back and in the second stage in the supraPubic and Its duration depends on the desire of woman. The acceptable duration for a first-time heat therapy is at least 60 minutes and in the second stage, at least 5 minutes. The temperature of the hot water bottle is adjusted between 38-40. The severity of pain will be measured in the dilatation 3-4, 7-8, 10-9 and the second stage of delivery with the Visual Analogue Scale (VAS). The duration of the first, second and third stages of labor, the first and fifth minute APGAR, mean heart rate, type of delivery, perineum status and maternal satisfaction will be assessed.</i_keyword>
      <i_keyword>Intervention group: Second intervention group: Cold Therapy. Before of any intervention, the severity of the pain in the 4 cm dilatation is measured by showing a graded ruler. the Ice Bag cover by thin cloth  and put  on back in the first stage and it put in second stage in the perineal and suprapubic . The acceptable duration for cold therapy is at least 60 minutes in the first stage and at least 5 minutes in the second stage. The temperature of the ice bag is between 0 to -5 degrees.The severity of pain will be measured in the dilatation 3-4, 7-8, 10-9 and the second stage of delivery with the Visual Analogue Scale (VAS). The duration of the first, second and third stages of labor, the first and fifth minute APGAR, type of delivery, perineum status and maternal satisfaction will be assessed.</i_keyword>
      <i_keyword>Control group: For the control group, the usual care is done.The severity of pain will be measured in the dilatation 3-4, 7-8, 10-9 and the second stage of delivery with the Visual Analogue Scale (VAS). The duration of the first, second and third stages of labor, the first and fifth minute APGAR, type of delivery, perineum status and maternal satisfaction will be assessed.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Initial Outcome Assessment of labor pain according to vas. Timepoint: Before intervention, dilatation of 3 cm, dilatation 5-6 cm, dilatation of 10-9 cm, and second stage of labor. Method of measurement: Visual Analogue scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iranshahr University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-06-19</approval_date>
        <contact_name>Ethics committee of Iranshahr University of Medical Sciences</contact_name>
        <contact_address>Balooch Blvd Iranshahr Sistan-va-Balouchestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
